You have read all your free articles, to continue reading subscribe to read the rest of this content.
Albireo, a company focused through its operating subsidiary on the development of bile acid modulators to treat orphan pediatric and adult liver diseases, NASH, and gastrointestinal disorders, has announced that Ron Cooper has joined the company as President and Chief Executive Officer. In additionAlready a subscriber Login You have read all…
AstraZeneca announce a new collaboration with Moderna Therapeutics to co-develop and co-commercialise immuno-oncology mRNA therapeutics and a new lung cancer clinical trial collaboration with Incyte. Lung cancer clinical trial collaboration The collaboration with Incyte aims to evaluate the eAlready a subscriber Login You have read all your free articles, to continue reading subscribe…
At the end of this year Karo Bio will transfer the responsibility of the Rorgamma project to their development parter Pfizer, according to the company’s interim report for the third quarter. The rorgamma project aim to develop treatments for auto immune diseases.Already a subscriber Login You have read all your…
Danish CDMO CMC Biologics and AGC Asahi Glass (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, have entered into a definitive agreement with CMC Biologics' shareholders including Monitor Clipper Partners, European Equity Partners and Innoven Partenaires, by which AGC Already a subscriber Login You have read all your…
